Sylvatica Biotech is 100% focused on vital organ and other complex tissue cryopreservation R&D – in order to transform transplantation and other areas of biomedicine. We are developing both our own IP and are partnering on joint development projects with leading institutions such as Harvard, UMN, UC Berkeley and Carnegie Mellon. Approaches that we are working on span nature inspired, high-subzero approaches, isochoric pressure based preservation and nanowarming enabled vitrification. We have to date received research funding from six different institutes at the NIH as well as the Defense Health Program and the US Army.
For more background on the need we are working to address see nature.com/articles/nbt.3889.pdf that several of our cofounders and scientific advisors are co-authors of and for some color on our approaches see this science feature by The Economist at https:// econ.st/2tLEcNt